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DEVELOPMENT OF AN INSTURMAL METHOD TO EVALUATE INSULIN RECEPTORS 
AND INSULIN-LIKE GROWTH FACTOR-1 RECEPTORS HOMODIMERS AND HYBRID 
RECEPTORS IN BREAST CANCER 
 
Breast cancer is a major public health problem in the United States and many other parts 
of the world.  It is the second most common cancer and second leading cause of cancer death 
among women in the US.  Insulin receptors (IR) and insulin-like growth factor-1 receptors 
(IGF1R) are found in normal mammary gland cells where they are involved in normal 
development and differentiation of these cells.  There is substantial clinical, epidemiological, and 
experimental evidence indicating that these receptors are also involved in initiation and 
progression of neoplasia of mammary gland cells.  IR and IGF1R numbers are increased in 
breast cancers and raise the possibility that IR and IGF1R may have roles in the biology of these 
tumors.  In this project, we have developed new methods to evaluate the presence of IR 
homodimers and hybrid receptors formed from IR and IGF1R monomers.  In initial experiments 
we have used three cell lines of CHO that stably express IR-GFP.  Using flow cytometry, we 
found that low expressing cells had ~ 62,000receptors/cell, moderately expressing cells had ~ 
130,000receptors/cell, and high expressing cells had ~ 205,000 receptors/cell.  We then used 
homo-transfer fluorescence resonance energy transfer (homo-FRET) methods to evaluate 
possible interactions between IR monomers in the IR homodimer or IR and IGF1R subunits in 
hybrid receptors.   Our results suggest that IR exists as an apparent monomer in cells expressing 






higher order receptor oligomers present on the plasma membrane.  These results suggest that 
when IR is highly expressed, as in the case in many breast cancers, the receptor is likely to be 
found as a IR homodimer rather than as a hybrid IR-IGF1R receptor.  Further studies beyond the 
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             Breast cancer forms in the cells of the breasts. It can occur in both men and women, but it 
is far more common in women.  Breast cancer is a major public health problem in the United States 
and many other parts of the world.  It is he second most common cancer and second leading cause 
of cancer death among women in the US.  An estimated 230,000 new cases of invasive breast 
cancer will be diagnosed in 2016 and approximately 40,000 women are expected to die from breast 
cancer (1).  Insulin receptors (IR) and insulin-like growth factor-1 receptors (IGF1R) are found in 
normal mammary gland cells where they are involved in normal development and differentiation 
of these cells.  There is substantial clinical, epidemiological, and experimental evidence indicating 
that these receptors are also involved in initiation and progression of neoplasia of mammary gland 
cells (2).  IR and IGF1R numbers are increased in breast cancer and raise the possibility that IR 
and IGF1R may have roles in the biology of these tumors (3,4).  Thus methods for evaluating the 
numbers of these receptors on tumor cells and evaluating receptor-receptor interactions would be 
clinically useful. 
 
Insulin receptor (IR) 
 
           The insulin receptor (IR) is a transmembrane receptor that belongs to the receptor tyrosine 
kinase (RTK) superfamily.  It is located in the plasma membrane of insulin-sensitive cells, e.g., 
adipocytes, myocytes, and hepatocytes. It mediates the effect of insulin on specific cellular 
responses including glucose transport, glycogen synthesis, lipid synthesis, and protein synthesis. 
The receptor homodimer is a heterotetrameric protein consisting of two extracellular α-subunits 






weight 95 kDa (Figure 1). These subunits are covalently linked by disulfide bonds to form a α2β2-
structure.  The receptor is encoded by a single gene which is located on human chromosome 19 
and consists of 22 exons where exons 1–11 make up the α subunit and exons 12–22 make up the 
β subunit. The single chain polypeptide precursor is post translationally cleaved in the endoplasmic 
reticulum into α and β subunits which subsequently dimerize.  Both subunits are glycosylated in 
the Golgi apparatus.  Alternative splicing of exon 11 generates two isoforms of α subunit.  Exon 
11 is absent in IR-A isoform, but is present in the IR-B isoform which has a 12-amino acid peptide 
located at the carboxyl-terminal end of the receptor’s α subunit.  The two receptor isoforms are 
also different in their C-terminus and in their affinity to bind insulin, IGF-1 or IGF-2 factors (5).  
In addition to insulin, insulin receptors can bind IGF-1 and IGF-2 but with different affinity. 
Insulin receptor has an affinity for IGF-1that is 100-1000 fold less than for insulin.  However, the 
A-isoform of insulin receptor binds IGF-1 and IGF-2 with same affinity as insulin (6). 
         The α subunit of IR has a molecular weight 135 kDa, and it consists of 723 amino acid 
residues.  It is glycosylated and located entirely extracellularly. Each α subunit is linked to one β 
subunit of same monomer by a class II disulfide bond.  The two α subunits in the α-β dimer of the 
insulin receptor are connected by interchain disulfide bond which is formed by cysteine 524 and 
cysteine 682 in the cysteine-rich domain of the α subunit (7).  The α subunit of IR contains the 
ligand binding sites in the cysteine-rich domain.  Besides the role of the cysteine-rich region of the 
α subunit in formation of disulfide bonds with the β subunit, it is possible that this region is 
involved in the binding of insulin.  Also, this region shows one of the lowest levels of sequence 
identity between IR and IGF1R, and this could cause the differences in the binding specificity of 






          In absence of insulin, the tyrosine kinase domain is inactive, but when the insulin binds to 
the ligand binding site on the α subunit, it brings the two α subunits closer together.  This 
conformational change causes ATP binding to the intracellular domain of β subunits which in turn 
leads to trans-autophosphorylation and subsequent receptor activation. Therefore, binding of 
insulin to α subunits turns on the receptor kinase activity.  As a result, the α subunit is considered 
to be the regulatory subunit of insulin receptor (6). 
           The β subunit (95 kDa) is composed of 620 amino acids and consists of both an intracellular 
and an extracellular domain that are anchored via a transmembrane domain which consists of 23 
amino acids.  The extracellular domain has O- and N-glycosylation sites. The intracellular portion 
of the β subunit contains the kinase catalytic domain (980-1255 amino acids ) flanked by two 
regulatory regions, a juxtamembrane region involved in docking of insulin receptor substrate (IRS) 
as well as functioning in receptor internalization. A C-terminal tail contains two phosphotyrosine 
binding sites, tyrosine 1328 and tyrosine 1334 (9).   
            Activation of the tyrosine kinase domain of IR is essential for the receptor function. The 
tyrosine kinase domain of IR is localized in the cytoplasmic region of the β subunit and contains 
many tyrosine residues. The three main tyrosine residues that have been recognized to play a 
functional role are tyrosine 1158, tyrosine 1160, and tyrosine 1162.  While several phosphorylated 
tyrosine residues in the catalytic domain are essential for receptor kinase activity, phosphorylation 
of the tyrosine residue 972 in the juxtamembrane domain and tyrosine 1328 and tyrosine 1334 in 
the carboxyl-terminal domain are also important. The juxtamembrane autophosphorylation site is 
essential for the interaction of the receptor with intracellular substrates and provides a docking site 
that increases the stability of receptor/substrate complex.  Tyrosine phosphorylation in the 








Although IGF-1 binds weakly to IR, it has its own high affinity receptor, IGF1R.  IGF1R 
is transmembrane protein that belongs to tyrosine kinase superfamily of receptors.  It is widely 
expressed in many cell types and different human tissues (11).  IGF1R binds both IGF-1and IGF-
2 with high affinity but binds insulin with very low affinity (12,13).  
IGF1R has important physiological functions i  regulation of cell growth and development 
and in protection from apoptosis.  Disturbance of IGF1R function leads to serious complications 
in mice including abnormalities in fetal growth, and in bone, skin, and the central nervous system 
(11).  The level of IGF1R is increased in many human cancers like breast carcinoma, and 
interference in the function of IGF1R may induce malignant transformation of normal cells in 
many cancer types (11).  Therefore, IGF1R is considered a therapeutic target for many hu  
cancers.  
IGF1R, like IR, is synthesized as a single polypeptide chain that is processed to form a 
glycopeptide with a molecular weight of 180 kDa (14).  The precursor protein contains polar 
residues in the terminal domain that function as a signal peptide facilitating the transfer of the 
nascent protein to the endoplasmic reticulum.  Then the precursor protein is partially processed to 
form the disulfide linked pro-receptor dimers which in turn are proteolytic cleaved at the basic 
tetrapeptide sequence (Arg-Lys-Arg-Arg).  The mature heterodimers have β-α-α-β conformation. 
IGF1R is a membrane glycoprotein (300-350 kDa) which consists of two extracellular ligand 
binding α subunits, each with a molecular weight of 135 kDa, and two transmembrane catalytic β 
subunits, each with a molecular weight of 90 kDa, connected together by disulfide bonds to form 
a functional heterotetramer (11).  The α subunit consists of a cysteine-rich region and several N-






it is used for high affinity binding of the IGF-1.  IGF1R is different from IR in that the N- and C-
terminal domains are both important for insulin binding.  The β subunit has a hydrophobic 
sequence that forms the transmembrane domain.  The cytoplasmic part of β subunit consists of 
juxtamembrane domain, a tyrosine kinase domain and the C-terminus region.  The juxtamembrane 
domain has an Asn-Pro-X-Tyr motif which is important in receptor internalization and the 
biological function of the receptor. The tyrosine kinase domain is the catalytic part of the receptor 
that contains a glycine-rich motif (Gly-X-Gly-X-X-Gly) which participates in transferring a 
phosphate group from ATP to specific intracellular substrates that initiate the signaling 
transduction after ligand binding to receptor (15).  The tyrosine kinase domains in IR and IGF1R 
are highly homologous. While the homology between the two receptors reaches 65-80% in the 
extracellular domains homology ranges from 45 to 65% (Figure 2) (12).      
           Although, the two receptors have a high degree of homology, experimental evidence 
suggests that each receptor has specific biological functions. IR is a key regulator in glucose 
metabolism and synthesis of glycogen and fat.  IGF1R has a specific role in regulation of cell 
growth and development (11).  The specificity of function for each receptor is due the difference 
in the relative expression of these receptors in the tissues.  For example, IRs are highly expressed 
in liver and fat cells where they have metabolic functions after ligand binding.  On the other hand, 
tissues that express more IGF1Rs than IRs, produce a response to IGF1R stimulation rather than 










Structure of the IR/IGF1R hybrid receptor  
 
          Both IR and IGF1R are highly homologous tetrameric complexes that are overexpressed in 
most human breast carcinoma cells.  Hybrid receptors are assembled randomly from one IR α and 
one β subunit hemicomplex and one IGF1R α and one β subunit hemicomplex.   IGF-1 binds to 
hybrid receptors with same affinity asto IGF1R, but it binds IR with very low affinity.  Therefore, 
the hybrid receptors behave like IGF1Rs rather than IRs.  In breast carcinoma cells, IGF-1 is locally 
secreted by the stromal fibroblast of breast cancer cells, but no insulin is secreted locally. The 
hybrid receptors become autophosphorylated in breast cancer cells when exposed to IGF-1rather 
than to insulin.  Collectively, hybrid receptors will be affected more by IGF-1 than insulin (2).     
 
 Signal transduction by insulin receptors, IGF1 R and hybrid receptors 
   
 The IRs, IGF1Rs, and hybrid receptors bind to the same ligands (insulin, IGF-1and IGF-
2), but with different affinities (Figure 5).  When the ligand binds to the α subunit of these 
receptors, a conformational change occurs that brings the two α subunits closer to each other, and 
this will induce the trans-autophosphorylation of one β subunit by another via specific tyrosine 
residues in the catalytic domain.  Activation of tyrosine kinase domain in the β subunit of both IR 
and IGF1R catalyze the phosphorylation of other tyrosine residues of insulin receptor substrate 
family of proteins (IRS-1,-2,-3,-4), Shc, APS, adaptor protein containing a PH domain and an SH2 
domain, and Gab1 (Grb2-associated binder 1).  
Among these various substrates, the IRS proteins are the most extensively characterized 






intracellular signaling cascade.  They have no kinase activity but, instead, serve as scaffolds for 
complexes to initiate the intracellular signaling cascades.  There are four groups of IRS.  IRS-1 
plays an important role in the biological function of metabolic and mitogenic pathway.  It may also 
play a role in cancer development; transgenic mice overexpressing IRS-1 develop breast cancer 
(16).  IRS-2 is important primary mediator of insulin-dependent mitogenesis and regulation of 
glucose metabolism in most cell types.  In addition it enhances survival and growth of insulin-
producing β cells in the pancreas (17).  IRS-3 is only expressed in rodents where it is most abundant 
in adipocytes.  It is tyrosine-phosphorylated in response to insulin in these cells (5).  IRS-4 is found 
predominantly in brain, liver, thymus, and kidney.  The phosphorylated tyrosine residues of IRS 
proteins recruit other intracellular molecules that contain the Src-homology-2 (SH2) domain, 
including the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K), the SH2-containing 
protein tyrosine phosphatase (SHP2) and the adaptor proteins GRP2 (growth factor receptor 
binding protein 2) (5).  This assembly of intracellular proteins with IRS will initiate subsequent 
downstream cascade of protein-protein interactions due to binding  of phosphorylated tyrosine 
residues of IRS to the Src-homology-2 (SH2) domain of signaling molecules like PI3K,  growth 
factor receptor binding protein 2 (GRP2), and SH2 domain of tyrosine phosphatase 2.  
PI3K consists of two subunits, a 110-kDa catalytic subunit (p110) and the 85-kDa 
regulatory subunit (p85) which has two SH2 domains (Figure 3) (10).  When the phosphorylated 
tyrosine of IRS binds to the SH2 domain of the regulatory subunit p85 of PI3K, they form a 
complex that facilitates the binding of the catalytic subunit of PI3K to the phospholipids in the 
plasma membrane.  This complex is consists of the receptor, IRS, and PI3K.  The activation of 
PI3K catalyzes the addition of phosphate on the D3 position of the inositol ring of 






(PIP3) in the cell membrane which acts as intracellular messenger that activates the PI-dependent 
kinases, stimulates growth, and changes the intracellular trafficking.  The activated 
phosphoinositide-dependent kinases (PDK1 and PDK2) are subsequently phosphorylated and 
activate the serine/threonine kinase Akt (protein kinase B, PKB).  Activated Akt has important 
metabolic functions as well as growth mediating functions (5).  Upon receptor activation, Akt, 
together with other atypical protein kinase C (PKC), stimulates the translocation of glucose 
transporter 4 (GLUT 4) from intracellular part to the cell membrane where it m diates glucose 
internalization.  Therefore, PI3K is essential for insulin-stimulated glucose transport (6).  In 
addition, PI-3K stimulates glycogen storage by inactivating glycogen synthase kinase 3 (GSK-3).    
Subsequently, glycogen synthase enzyme will be active, increasing the rate of glycogen synthesis 
(18).    
           Akt is able to phosphorylate the Forkhead box protein O1 (FOXO1), previously known as 
forkhead in rhabdomyosarcoma (FKHR), a transcriptional enhancer that responds to insulin and 
other growth factors.  It is a nuclear protein that regulates the genes controlling apoptosis, glucose 
production and cell cycling.  When the PI3K pathway is active, FOXO1 is phosphorylated by Akt 
which then moves from the nucleus to cytoplasm leading to inhibition of gene expression (6).   
            IR and IGF1R also affect protein synthesis and degradation by activation of the target of 
rapamycin (mTOR) pathway.  mTOR is a serine/threonine protein kinase encoded by mTOR gene 
in human.  It has important functions in protein synthesis, transcription, translation, cell growth, 
and autophagy. Upon PI3k/Akt pathway activation, mTOR is activated and directly phosphorylates 
the p70 ribosomal S6 (S6K) kinase which is a regulatory enzyme for translation.  Also, it 
phosphorylates the eukaryotic initiation factor binding protein (4EBP1) which bound to S6K, and 






initiation factor 3 (eIF3) translation initiation complex leading to increase the translation of mRNA 
(19).   
            The PI3K/Akt pathway is inhibited by other phosphatase enzyme which is PTEN, 
phosphatase and tensin homology.  PTEN is tumor suppressor protein encoded in human by PTEN 
gene that dephosphorylates the second messenger of PI3K which is phosphatidylinositol (3, 4, 5)-
trisphosphate (PtdIns (3, 4, 5) P3).  In this way it inactivtes the Akt pathway and inhibits the cell 
cycle and survival (Figure 4) (20).   
            The second major signaling pathway for IR and IGF1R is the mitogen-activated protein 
kinase (MAPK) pathway which plays a critical role in the regulation of cellular growth, survival, 
and gene expression.  Abnormal MAPK signaling may cause uncontrolled cell proliferation and 
resistance to apoptosis.  The phosphorylation of tyrosine residues of IRS proteins and/or Shc cause 
interactions between IRS and Grb2 adaptor protein which in turn recruits another exchange protein 
called Son-Of-Sevenless (SOS). This event causes translocation of SOS to the plasma membrane 
for activation of RAS, a small GTPase. RAS is usually in its inactive state bound to GDP 
(guanosine diphosphate), and it is transiently activated when SOS displaces the GDP from Raf 
which allows GTP to bind.  The activated RAS acts as adaptor protein and binds to Raf kinases 
(Rapidly accelerated fibrosarcoma kinases) with high affinity causing their translocation to the cell 
membrane and activation.  Therefore RAS activates Raf which is known generally as mitogen-
activated protein kinase (MAPKKK) and which phosphorylates the second protein kinase in this 
cascade, MAPKK (MEK).  The MAPKK activates the final kinase enzyme in this pathway which 
is the MAPK by phosphorylation of tyrosine residue and threonine residue.  Then MAPK becomes 
active and translocated to nucleus where it activates transcription factors and regulates gene 






           Although, the IRS and Shc pathways are common signaling pathways for both the IR and 
IGF1R, a specific interaction of IR and IGF1R with IRS-1 and IRS-2 may be the key to the distinct 
functions of each receptor.  For example, the proto-oncogene c-Crk or p38 is widely express d 
pro-oncogene that associates with IRS-1 and IRS-2 and interacts directly with the IGF1R via the 
SH2 domain but not with IR. On the other hand, IR downstream signaling causes 
dephosphorylation of tyrosine residues on protein tyrosine kinase 2, also called Focal Adhesion 
Kinase FAK, which is a focal adhesion-associated protein kinase involved in cell adhesion by actin 
and cellular movement. When FAK is blocked, breast cancer cells became less metastatic due to 
decreased mobility (22).  
  
 Do IRs and IGF1Rs in breast cancer use the same physiological signaling system? 
 
        Although, the IR and IGF1R are highly homologous, the normal biological function for each 
receptor is distinct.  Whereas IRs have important roles in the regulation of many metabolic 
processes via PI3K signaling system, IGF1Rs regulate growth and development via the MAPK 
pathways.  However, in breast cancer cells, the signaling specificity of these receptors i  lost.  Both 
the PI3K and MAPK intracellular signaling pathways are activated.  Various mechanisms are 
responsible for disturbance of the physiological functions of IRs and IGF1Rs.  One of these 
mechanisms is the overexpression of both receptors and hybrid receptors. In addition, the local 
production of IGFs factors from tumor cells occurs in autocrine-paracrine manner, and these 
factors bind to hybrid receptors with high affinity.  Finally, there is a chronic increase in insulin 
levels in blood due to insulin resistance.  This causes activation of IR signaling through mitogenic 






 The role of IR and IGF1R in breast cancer 
 
            Although insulin and insulin-like growth factor 1 share extensive sequence homology and 
share downstream signaling pathways, IGF1R exhibits stronger mitogenic and anti-apoptotic 
effects. IGF1R is a potent mitogen for both normal and transformed breast epithelial cells and 
increased serum IGF-1 levels are associated with the development of mammary gland hyperplasia 
and cancer (4).  In addition, the presence of the IGF1R is required for development of a neoplasia. 
With a few exceptions cells lacking IGF1R do not undergo malignant transformation (3).   
     Studies performed by specific ELISAs have indicated that approximately 80% of breast cancers 
have IR content higher than the mean value found in normal breast and approximately 20% of 
cancers have IR at least 10-fold higher than normal breast tissue (23).  Functional studies indicate 
that IR expressed in breast cancer is more sensitive to insulin than is normal breast tissue, and 
patients whose tumors have high IR content have a lower 5-year disease-free survival than patients 
with tumors with moderate IR content (24).  Analysis of these data to establish prognostic factors 
for breast cancer have confirmed that IR content is the strongest independent predictive factor for 
disease free survival.  However, IR overexpression is not specific to breast cancer but seems to be 
a common phenomenon in cancer, IR overexpression is not occurs only in breast cancer, but also 
in colon, lung, ovary, and thyroid cancer (5).    
            The possible mechanism for IR overexpression in breast cancer cells is the inactivation of 
P53 (tumor suppressor protein) and activation of HMGA1 (High-Mobility Group A1) proteins.  
This finding explains at least in part why IGF1R are overexpressed in most human cancer (23).  
P53 has many anticancer functions and plays a role in apoptosis, genomic stability, and inhibition 






are encoded by the HMGA1 genes.  They are involved in many cellular processes including gene 
transcription, DNA replication, and metastatic progression of cancer cells. In addition, they have 
the ability to bind to DNA forming multi-complexes that regulate gene transcription.  The 
expression of HMGA1 is directly correlated with transformation and metastasis of tumors and also 
participates in the regulation of IR transcription (25).  Some studies indicate that HMGA1 inhibits 
P53, a tumor suppressor protein, so it may be involved in up-regulation of IR in cancer cells by 
inactivating p53 factor. Thus, these data suggest that IR overexpression is driven by multiple 
mechanisms that are activated during development of cancer (24).  Some of these mechanisms also 
cause IGF1R overexpression.  Like other growth factors, insulin is able to stimulate cell motility 
toward a ligand gradient (26).  This effect requires IR autophosphorylation and activation of the 
same signaling pathways involved in mitogenesis. Furthermore, IR enhances the tumor cells 
metastasis, so the breast cancer cells overexpressing IRs may have an increased metastatic 
potential (24).  
           On the other hand, IGF-1 is a hormone related to insulin that is also considered to be an 
endocrine risk factor for breast cancer (4).  In recent years it has become clear that IGF-1 has a 
significant role in cancer development and progression (27).  Some studies show that IGF1Rs in 
breast cancer are more critical than IRs as IGF-1 together with IGF1R has more potent 
transformation effects on breast cells (24).  Clinical evidence suggests that there is a link between 
IGF1R and breast epithelial cell transformation because the expression level of IGF1Rs is higher 
in breast cancer tissue than adjacent normal tissue.  However, IGF1R and IR can form hybrid 
receptors by heterodimerization and these hybrid receptors have a high affinity for IGF-1 and IGF-
2and lower affinity for insulin.  Hybrid receptors behave functionally like IGF1Rs rather than IRs. 






of breast cancer by increasing the rate of tumor proliferation and metastasis potential.   Because 
IR also activates signaling pathways similar to IGF1R in breast cancer cells, agents targeting both 
receptors may be necessary to disrupt the malignant phenotype regulated by this growth factor 
system (28).  
  
Methods used for counting IR and IGF1R 
 
 Counting receptor numbers is an important first step in determining the role of IR and 
IGF1R in breast cancer development and progression.  A number of methods have been developed 
that can accomplish this.  Most of these methods have major limitations and are not likely to be 
useful in a clinical setting.  These methods are discussed below.  
 
Polyacrylamide gel electrophoresis 
 
Polyacrylamide gel electrophoresis is a method to separate proteins and macromolecules. 
It has been used to count receptors like IR and IGF1R during the 1980s.  It separates molecules 
according to their molecular weight and charges.  It is usually done using binding of photo-labeled 
insulin or IGF-1 to cells or membranes that express IR, IGF1R, or both receptors. The proteins 
labeled with 125I-insulin or 125I-IGF-1 are identified by electrophoresis and autoradiography and 
they appear as radiolabeled bands.  The intensity of these bands reflects the expression rate of these 
receptors.  However, this method cannot measure exactly the molecular weight of IR or IGF1R; it 
gives an estimate of numbers because the glycosylated proteins have very slow mobility on 






between insulin binding components and other membrane constituents with detergents and gel 
buffers. This could be a major source of result errors (29).   
 
Selective immunoadsorption of radioligand or radio-labeled receptor complexes and 
immunoblotting 
 
This method is used to detect the fraction of IR and IGF1R that form hybrid receptors in 
different tissues that express both receptors.  In this method, receptors are isolated from 
membranes of tissues with a specific detergent, and then incubated with 125I-IGF-1.  After selective 
immunoadsorption of radioligand receptor complexes, immunoblots are prepared and probed 
using specific IR and IGF1R antibodies to the receptors.  Therefore, IR and IGF1R levels are 
estimated by blotting.  The level of IR and IGF1R does not reflect the level of hybrid receptors 
because of heterogeneity of receptor expression between different tissues (30).   
     
Fluorescence Correlation Spectroscopy (FCS)  
 
This technique was developed by Elliot Elson in the 1970s.  It measures the fluctuation of 
fluorescence intensity in a sub-femtoliter volume, a tiny volume excited by a laser source. This 
method is used to detect some dynamic biological processes like concentration localization of 
proteins and lipids within the cells, interactions between ligand and receptor on cell membrane, 
and rate of diffusion of some molecules.  Some studies have used FCS to measure the density and 
thermodynamics of insulin and IGF1 receptors (31).  IR and IGF1R are labeled with specific 
antibodies against the α or β subunit of each receptor and, as a result, the number of IRs and 






isothiocyanate-insulin (FITC-insulin), the total number of IRs is slightly lower than estimated 
using specific antibodies.  However, FCS measurement of IRs and IGF1Rs using a specific 
antibodies or fluorophore-conjugated ligands such as FITC-insulin is only estimation and not 
accurate because it measures all binding of fluorescent ligands to receptors including IR/IGF1R 
hybrid receptors (32).   
 
Methods for evaluating IR or IGF-1R organization as homodimers or hybrid receptors  
 
Single Molecule Localization Microscopy (SMLM) 
 
           Previous methods that studied interactions and organization of molecules in the cell 
membranes were dependent on the classical biochemical measurements and assays.   Using new 
methods that depend on super resolution imaging like single molecule localization microscopy, 
biologists can assess the organization of molecules in the cell membrane directly.  SMLM can 
overcome limitations of standard fluorescence microscopy that identify protein co-localization 
within 250 nm.  Due to the high resolution obtained by SMLM, two proteins can be co-localize to 
around 25 nm making SMLM useful for the detection of detect receptor clustering, aggregation, 
and signaling.  SMLM is done on IR and IGF1R in presence and absence of insulin in cell medium 
and data shows clustering of both receptors.  In addition, they can measure the accurate numbers 
of each receptor in cluster exactly, distance between clusters, and distance between receptors.  On 
the other hand, single molecule imaging is more complicated than standard fluorescence 
microscopy because it is computational and requires the use of different fluorophores, some of 






it affects the sharpness of constructed images and facilitates observation of fine details within the 
image, so SMLM is time consuming and technically demanding (32).   
 
Homo-transfer or Hetero-transfer fluorescence resonance energy transfer (FRET)  
 
              These are techniques that provide measurements of interactions between partner 
molecules in live cells (33). They are based on energy transfer between two molecules, an energy 
donor and an energy acceptor.   FRET depends on the distance between the donor and acceptor.  
Energy transfer occurs when the intermolecular distances are within 1-10nm.  When the two 
fluorophores are the same, the technique is called homo-transfer FRET.  If the fluorophores are 
different, the technique is called hetero-transfer FRET. In both types of FRET, there must be 
sufficient overlap between excitation and emission spectra of donor and acceptor fluorophores.   
Hetero-FRET has some limitations and complication because it occurs between two 
different fluorophores.  One of these complications is difficulties in interpreting results when the 
level of expression for fluorophore-tagged proteins is different.  In addition, when the receptors 
organized in higher oligomers than dimers especially in regions that are crowded with protein 
clusters like the cell membrane, hetero-transfer FRET cannot distinguish dimers from other 
clusters.  However, homo-transfer FRET is simpler than hetero-transfer FRET because it uses only 
a single fluorophore.  Also, it is highly sensitive to oligomerization of proteins between the 
fluorophores because it proportional to the six power of distance between the donor and acceptor 
molecules in nanometer scale. 
 In these studies, polarization homo-transfer FRET methods were used to evaluate 






occurs only when the donor GFP and acceptor GFP molecules are within 2 -10 nm distance of one 
another (34). Homo-FRET id highly sensitive to distance between donor and acceptor because the 
FRET efficiency is inversely proportional to the six power of distance (r) between the two 
molecules (39). 
  E=1/ (1+r/R06)  
          Where E is FRET efficiency, r is distance between donor and acceptor, and R0 is the 
Forster distance between donor and acceptor at which 50% of energy transfer occurs.  
         Homo-transfer FRET data is collected from two detectors in a Zeiss Axiovert 200M 
microscope using an Andor Du897E EMCCD camera.  Images were acquired using an arc lamp 
for fluorescence excitation together with a polarized excitation filter, a GFP emission filter and a 
63x water objective for observing cells.  The two detectors collect vertical and horizontal emission 
images that represent fluorescence parallel to polarization of excitation light, and anisotropy of the 
emitted light can be measured from the following equation: 
             r = (Ivv - GIvh)/ (Ivv+2GIvh) 
 r is the anisotropy of emitted light, Ivv is the fluorescence intensity of emission that is vertical to 
excitation light, Ivh is fluorescence intensity of emission that is horizontal to excitation light. G is 
G factor that is used as correction factor for different sensitivities in detection of vertical and 
horizontal fluorescent intensities (39). 
        Image J software is then used to obtain the vertical and horizontal fluorescence intensities 
from cell measurements and for calculation of the G factor as discussed in “Results and 
Discussion”.   These studies assume that the fundamental anisotropy of the GFP fluorophore is 






The goal of these studies was to use homo-transfer FRET methods to determine whether 
there were differences in the organization of IRs when receptors numbers per cell are 
comparatively low or significantly higher as may occur in more aggressive forms of breast cancer.  
We hypothesize that in cells that highly expressing IR-GFP, IR monomers appear apparently as 
IR homodimers, and in cells expressing low numbers of IR-GFP, most IR appear as monomers 












Figure 1. Subunit structure of the insulin receptor. Schematic diagram of the IR subunit 
organization and major structural features. The insulin-binding domain is localized to the N-
terminus of the α subunit. The β subunit intracellular domain contains the tyrosine-specific protein 
Kinase activity. Several tyrosine residues are phosphorylated in the receptor’s juxtamembrane 
domain (tyrosine 965 and 972), catalytic loop (tyrosine 1158, 1162, and 1163), and carboxyl-
terminal domain (tyrosine 1328 and 1334). The variably spliced exon 11 is indicated at the COOH-











Figure 2. Structure of IGF1R. IGF1R consists of α–β subunit dimers. The percentage of 












Figure 3.  Insulin signaling pathways. SOS, son-of-sevenless; GAP, GTPase-associated protein; 
PDK, PI-dependent protein kinase; MAPKK, mitogen-activated protein kinase kinase; MAPK, 









Figure 4.  IGF1R signaling cascades. IGF1R or hybrid receptor can be activated by their ligands 
IGF-1 and IGF-2, whose bioavailability is regulated by IGF-binding proteins (IGFBP). Insulin 
receptor substrate (IRS) proteins or Shc couple activated IR to Grb2/SOS, leading to the activation 
of Ras/Raf/mitogen-activated protein kinase (MAPK) kinase (MEK)/extracellular signal-regulated 
kinase (ERK) pathway. Activated extracellular signal-regulated kinase promotes cell proliferation. 
Insulin receptor substrate proteins also couple the receptor to phosphatidylinositol 3-kinase (PI3-
K) activation. Activated phosphatidylinositol 3-kinase phosphorylates PIP-2 to PIP-3, which 
recruits Akt to the plasma membrane. Akt is activated by phosphoinositide-dependent kinase 
(PDK). The lipid phosphatase PTEN can dephosphorylate PIP-3 to inhibit the activation of 








Figure 5. Schematic diagram of IR, IGF1R, and hybrid receptor signaling. IR, IGF1R and 
hybrid receptors induce the phosphorylation of IRSs proteins which trigger activation of two 












  Chinese Hamster Ovary cells (CHO) were purchased from ATCC (American Type Culture 
Collection), (Manassas, VA). Dulbecco’s Modified Eagle medium (DMEM) to maintain CHO 
cells were purchased from Corning Cellgro (Visalia, CA).  Geneticin (G418 sulfate) added to 
DMED was also purchased from Cellgro.  Fetal bovine serum (FBS) was purchased from Atlas 
Biologicals (Fort Collins, CO).  L-glutamine and penicillin/Streptomycin solutions were purchased 
form Gemini Bio-products (West Sacramento, CA).  MEM non-essential amino acids and EDTA 
(ethylene diamine tetraacetic acid) were purchased from Sigma Aldrich (St. Louis, MO).  
Rhodamine 6G (R6G) was purchased from Allied Chemical (Vadodara, Gujarat. India).  Glass 
bottom cell culture dishes (WillCO) with 35 mm diameter and 14 mm diameter glass bottoms were 
purchased from In Vitro Scientific (Sunnyvale, CA). 
 
Cell culture and cell lines 
 
We used three cell lines of CHO cells that stably express insulin receptors tagged with 
green fluorescent protein (GFP) to the C-terminus of the insulin receptor. The first cell line 
expressed low numbers of insulin receptors (IR ~62,000 receptors/cell). The second cell line 
expresses moderate numbers of insulin receptors (IR ~ 130,000 receptors/ cell).  The third cell line 
expresses high number of insulin receptor (IR ~205,000 receptors/cell).  CHO IR-GFP cells are 






penicillin/streptomycin solution.  All cells are grown in plastic 25 cm2 culture flask in incubator at 
37℃ with humidified environment and 5% CO2. 
 
Preparation of cell samples for homo-transfer FRET studies 
          
CHO stably expressing IR tagged with GFP were maintained in culture flasks in an 
incubator with MEM medium.  Then the medium was removed and 5 ml of EDTA was added to 
the culture flask and incubated for 5 minutes.  Cells were then diluted with medium and platted in 
35mm bottom glass dishes and incubated from 1-2 days until they occupied at least 70% of the 
plate surface.  At time of the experiment, cells are washed twice by 1 X PBS (phosphate buffered 
saline) PH 7 and resuspended in 1-2ml PBS.  After that, images were taken by Ziss Axiovert 200 
M inverted microscope in a dark room with all light sources turned off except for arc lamp 
illumination. 
 
Use of flow cytometry to determine receptor numbers 
               
Flow cytometry is a techniqnique that is used to measure different physical and chemical 
characterestics of cells such as cell size and shape, cell surface markers, DNA content, location of 
cell organelles and viability. We used flow cytometry to measure the numbers of IR in the three 
CHO cell lines. CHO cells experssing IRs which are labeled with GFP were put in a microfluid 
system that directs the cells in a single stream with a laser is focused on each single cell. Then, the 
flow cytometer captures the scattered light and emitted fluorescence at different angles d 
different wave lengths for each cell.  Signals are collected and analysed electronicly to provide the 






IR-GFP.  Using flow cytometry, we found that low expreesing cells had~ 62,000 receptors/cell, 
moderately expressing cells had ~130,000 receptors/cell, and high expressing cells had ~ 205,000 
receptors/cell. 
 
Results and Discussion 
 
Experimental Determination of the G factor  
 
The G factor is the correction factor for different detection sensitivities of vertical and 
horizontal polarized fluorescence in our instrumental setup.  It acts as a normalization factor to 
compensate for optical properties such as reflections from mirrors that may change the 
polarization angle of excitation light.  The G factor can be measured using aqueous solutions that 
have anisotropy values near zero such as Rhodamine 6G, which has an anisotropy value of about 
0.012 (36,37).  The G factor is then calculated using the following equation described by Dix and 
Verkman (36).  
      G = (1/F) (1-R)/ (1+2R) 
 Where F is the difference in sensitivity of detection system that is used to detect the fluorescence 
vertical and horizontal intensities of emitted light of Rhodamine 6G subtracted from that for H2O 
as in following equation:  
       F = (Ivv R6G – Ivv H2O) / (Ivh R6G - Ivh H2O) 
Where Ivv is fluorescence intensity that is parallel directed to vertical polarization light of R6G 
and H2O.  Ivh is fluorescence intensity that has perpendicular direction to vertical polarization 






the range values measured for our samples were from 1.5 to 1.7.  These values indicate that the 
sensitivity of detection in our Zeiss Axiovert 200M microscope is higher for vertical polarization 
compared to horizontal polarization. 
 
Establishing Parameters for Photobleaching of IR-GFP 
 
We next established the time required for photobleaching of IR-GFP in cell lines 
expressing low, moderate and high numbers of IR-GFP.  Representative experiments shown in 
(Figures 6) demonstrate that >90% photobleaching of GFP was achieved in approximately 20 
minutes for each of the cell lines used.  In subsequent experiments, anisotropy data were 
collected for 12 minutes at 20 seconds per point.   
 
 
Polarized homo-transfer FRET measurements of IR-GFP 
 
        Polarized homo-transfer FRET measurements were made using three cell lines that stably 
express IR-GFP where GFP is coupled covalently to the C-terminus of IR.  The first cell line 
expresses low numbers of IR (~ 62,000 receptors/cell); the second cell line expresses moderate 
numbers of IR (~ 130,000 receptors/ cell); and, the third cell line expresses high numbers of IR 
(~ 205,000 receptors/cell).  These receptor numbers were determined by flow cytometry.   The 
mean, standard deviation and standard error of the mean for each data point obtained in homo-
transfer FRET measurements were calculated for 10,9,8 cells, respectively.  Anisotropies were 






 In cells expressing low numbers of IR, the initial anisotropy was approximately 0.33 
compared to a predicted value of 0.38 for receptor monomers (Figure 7).  This small difference 
between the observed and predicted value for a GFP monomer suggests that, when levels of IR 
expression are low, IR exists predominantly as a monomer.  This is an interesting result given the 
factor that IR monomers are typically organized as homo-dimers or are half of an IR-IGF1  
hybrid receptor.  Thus low expressing receptors in these experiments may exist as true monomers 
or are part of IR-IGF1R hybrid receptors that appear, in these studies to be indistinguishable from 
IR monomers. 
 As receptor numbers per cell increase in cell lines expressing moderate or higher numbers 
of IR, the initial anisotropies decreased to 0.29 and 0.27, respectively (Figure 7). These results 
suggest that, with increasing levels of IR-GFP expression, more receptors are present as either IR 
homodimers or as receptor clusters containing either IR homodimers or hybrid receptors.  A 
comparison of initial and final anisotropies (Table 1) for the three cell lines suggest that cluster 
sizes increase with increased expression of IR per cell.  In addition, there is inverse relationship 
between the fluorescence intensity and anisotropy for the three cell lines because when the 
fluorescence intensity is high, the anisotropy is at it is lower value.  While cells lose it is 
fluorescence intensities upon progressive photobleaching, the anisotropy is increases until it 
reaches maximum value (Figure 8) 
 In conclusion, polarized homo-transfer FRET permits us to monitor the oligomerization 
state of IR when receptors are expressed at various densities.  These are the first studies to 
demonstrate a relationship between cluster formation and IR receptor number/density although 
similar results have been demonstrated for two G protein-coupled receptors, the serotonin 1A 






numbers, the likelihood of molecular crowding is reduced by the use of stable cell lines that are 
unlikely to exhibit large cell-to-cell variations in receptor number as is the case for transiently 







      
 
 
Figure 6. Intensity of the three cell lines (low, moderate, and high expressing CHO IR-GFP 
upon progressive photobleaching for 700 seconds.  Images are taken every 20 seconds, and the 




















































Figure 7. Fluorescence anisotropy for low, moderate, and high expressing CHO-IR-GFP 










































Figure 8. Increase in anisotropy with progressive loss of fluorescence intensity in the three 
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Table 1: Difference between initial fluorescence anisotropy and final fluorescence 
anisotropy for three cell line expressing IR-GFP 
 
Cell line Initial anisotropy Final anisotropy 






Moderate expressing cells  

































Conclusions and Future Directions  
 
 These studies desmonstrate that increased IR-GFP numbers per cell are likely to result in 
the formation of either IR homodimeric receptors or clusters of IR homodimers and hybrid 
receptors that exhibit FRET.  There are, however, serious limitations to these studies which 
should be addressed.   
 First, it is not clear whether IR exists as a true receptor monomer when receptor numbers 
are low.  It is possible that under these conditions, IR is participating in hybrid receptors formed 
from IR and IGF1R monomers.  To determine whether this is the case, future studies will use 
cell lines that express various numbers of IGF1R-mCherry together with IR-GFP.  Fluorescence 
correlation methods will then be used to distinquish IR monomers which will travel 
independently from IGF1R-mCherry from hybrid receptors where motions of both GFP and 
mCherry are correlated to one another.   
 Second, when IR receptor numbers are high, the formation of IR homodimers cannot be 
distinguished readily from larger receptor clusters that contain either IR homodimers or mixtures 
of IR homodimers and hybrid receptors.  Again, fluorescence correlation spectroscopy will 
address question in cells that are stably expressing both larger numbers of IR-GFP and IGF1R-
mCherry.  We believe that as the relative numbers of IGF1R-mCherry increase, the likelihood of 
IGF1R-mCherry homodimers will also increase and the number of hybrid receptors will 
decrease.   
 Finally, the overall goal of this project is to assess numbers of IR and IGF1R on breast 
cancer cells.  Although homo-transfer FRET is a relatively straightforward techniques, this 






expression levels on normal and breast cancer cells.  To achieve this, the first step will be to 
evaluate IR and IGF1R numbers using both homo-transfer FRET methods as described in this 
thesis together with fluorescence correlation spectroscopy methods.  There are a number of 
breast cancer cell lines where receptor levels have been characterized and these will be used in 
initial work.  Ultimately, a more robust method is desirable that evaluates homotransfer-FRET 
using a single fluorophore and then calculates the relative numbers of IR and IGF1R 
homodimers and hybrid receptors from apparent numbers of receptor monomers (present in 
hybrid receptors) and receptor dimers.  Such a method will only be possible if IR and IGF1R 
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IR: insulin receptor 
IGF1R: insulin-like growth factor one receptor  
IGF-1: insulin-like growth factor 1 
IGF-2: insulin-like growth factor 2 
GFP: green fluorescent protein 
Homo-FRET: homo-transfer fluorescent resonance energy transfer 
Hetero-FRET: hetero-transfer fluorescent resonance energy transfer 
α: alpha 
β: beta 
ATP: adenosine triphosphate 
IRS: insulin receptor substrate  
PI3K: phosphatidylinositol 3-kinase  
GRP2: growth factor receptor binding protein  
SH2: 2 Src-homology-2 domain  
Gab: Grb2-associated binder 1  
PKC: protein kinase C 
PDK1 and PDK2: phosphoinositide-dependent kinases 1 and 2 
PIP3:  phosphatidylinositol (3, 4, 5)-triphosphate 
PIP2: phosphatidylinositol 4, 5-bisphosphate  
GSK-3: glycogen synthase kinase 3    






mTOR: target of rapamycin 
GLUT 4: glucose transporter 4 
MAPK: mitogen-activated protein kinase  
SOS: Son-Of-Sevenless  
HMGA1: High-Mobility Group A1 proteins 
P53: tumor suppressor protein 
GDP: guanosine diphosphate 
CHO: Chinese hamster ovary cells 
 DMEM: Dulbecco’s modified minimum essential medium 
EDTA:   ethylenediaminetetraacetic acid 
FBS:   fetal bovine serum 
G418:   genticin 
PBS:   phosphate buffered saline 
FCS: Fluorescence Correlation Spectroscopy  
FITC-insulin: fluorescein isothiocyanate-insulin 
SMLM: Single Molecule Localization Microscopy  
 
 
 
 
 
 
 
